Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
Related Questions
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
Is there a role for prophylactic Trental and vitamin E in a patient at high risk for osteoradionecrosis?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
How would updated results of ECOG 3311 (56 month) influence your adjuvant RT recommendations for HPV+ OPSCC?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
How do you treat SNUC?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
